“PTS Diagnostics brings certified accuracy, precision, and speed together to further innovate the point-of-care,” said Richard Simon, producer for the Advancements series.
WEST PALM BEACH, Fla. (PRWEB)
July 20, 2020
Scheduled to broadcast in the fall of 2020, Advancements with Ted Danson will focus on recent improvements in diagnostics technologies and solutions. Check local listings for more info.
In an upcoming episode, the Advancements series will explore how PTS Diagnostics is influencing innovation through its point-of-care diagnostics solutions. Viewers will learn how, through its people, technology, and service, the company creates health innovation that drives action and connects people to improved outcomes.
“We’re excited to be showcased as one of the Advancements series’ featured stories,” said Jonathan Chapman, President and CEO of PTS Diagnostics. “Our goal within the segment is to educate the community about the growing need for closing potential gaps in patient medical care and to inform them of our organization’s ability to potentially improve the outcomes of those living with chronic conditions. This current pandemic has created a phenomenon of Medical Distancing, whereby high-risk populations are not seeking the services to help them assess and manage their medical risks. We believe our solutions can play an integral role in addressing this present growing crisis.”
Audiences will learn about PTS Diagnostics’ extensive and expanding patent portfolio, including its fingerstick, point-of-care blood collection, diagnostics, and information management products, which are widely used for testing heart disease, diabetes, and more.
“PTS Diagnostics brings certified accuracy, precision, and speed together to further innovate the point-of-care,” said Richard Simon, producer for the Advancements series. “We look forward to educating audiences on this technology.”
About PTS Diagnostics:
Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, PTS Diagnostics has helped medical professionals and patients achieve better health outcomes through its accurate, precise, fast, affordable, and certified point-of-care medical devices. Healthcare professionals have used PTS Diagnostics’ CardioChek® products to assess cardiovascular disease risks for more than 140 million patients worldwide through lipid panel screening and have used its PTS Connect biometric information management solutions to turn data into actionable reports. PTS Diagnostics’ A1CNow+® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. From its headquarters in the United States of America, PTS Diagnostics designs, manufactures, and markets its products to hundreds of countries around the globe. For more information, visit: http://www.ptsdiagnostics.com.
About Advancements and DMG Productions:
The Advancements series is an information-based educational show targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today’s consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.
Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming on which both viewers and networks depend.
For more information, please visit http://www.AdvancementsTV.com or call Richard Simon at 866-496-4065.
Share article on social media or email: